These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 33904021)
1. Withaferin A Induces Heat Shock Response and Ameliorates Disease Progression in a Mouse Model of Huntington's Disease. Joshi T; Kumar V; Kaznacheyeva EV; Jana NR Mol Neurobiol; 2021 Aug; 58(8):3992-4006. PubMed ID: 33904021 [TBL] [Abstract][Full Text] [Related]
2. Azadiradione Restores Protein Quality Control and Ameliorates the Disease Pathogenesis in a Mouse Model of Huntington's Disease. Singh BK; Vatsa N; Nelson VK; Kumar V; Kumar SS; Mandal SC; Pal M; Jana NR Mol Neurobiol; 2018 Aug; 55(8):6337-6346. PubMed ID: 29294248 [TBL] [Abstract][Full Text] [Related]
3. Topoisomerase 1 inhibitor topotecan delays the disease progression in a mouse model of Huntington's disease. Shekhar S; Vatsa N; Kumar V; Singh BK; Jamal I; Sharma A; Jana NR Hum Mol Genet; 2017 Jan; 26(2):420-429. PubMed ID: 28007908 [TBL] [Abstract][Full Text] [Related]
4. Dexamethasone induces heat shock response and slows down disease progression in mouse and fly models of Huntington's disease. Maheshwari M; Bhutani S; Das A; Mukherjee R; Sharma A; Kino Y; Nukina N; Jana NR Hum Mol Genet; 2014 May; 23(10):2737-51. PubMed ID: 24381308 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of heat shock protein 70 in R6/2 Huntington's disease mice has only modest effects on disease progression. Hansson O; Nylandsted J; Castilho RF; Leist M; Jäättelä M; Brundin P Brain Res; 2003 Apr; 970(1-2):47-57. PubMed ID: 12706247 [TBL] [Abstract][Full Text] [Related]
6. VGLUT3 Deletion Rescues Motor Deficits and Neuronal Loss in the zQ175 Mouse Model of Huntington's Disease. Ibrahim KS; El Mestikawy S; Abd-Elrahman KS; Ferguson SSG J Neurosci; 2023 Jun; 43(23):4365-4377. PubMed ID: 37055181 [TBL] [Abstract][Full Text] [Related]
7. Mutant Huntingtin reduces HSP70 expression through the sequestration of NF-Y transcription factor. Yamanaka T; Miyazaki H; Oyama F; Kurosawa M; Washizu C; Doi H; Nukina N EMBO J; 2008 Mar; 27(6):827-39. PubMed ID: 18288205 [TBL] [Abstract][Full Text] [Related]
8. HSF1 and Its Role in Huntington's Disease Pathology. Kim H; Gomez-Pastor R Adv Exp Med Biol; 2023; 1410():35-95. PubMed ID: 36396925 [TBL] [Abstract][Full Text] [Related]
9. Targeting the proteostasis network in Huntington's disease. Soares TR; Reis SD; Pinho BR; Duchen MR; Oliveira JMA Ageing Res Rev; 2019 Jan; 49():92-103. PubMed ID: 30502498 [TBL] [Abstract][Full Text] [Related]
10. The heat shock response, determined by QuantiGene multiplex, is impaired in HD mouse models and not caused by HSF1 reduction. Gomez-Paredes C; Mason MA; Taxy BA; Papadopoulou AS; Paganetti P; Bates GP Sci Rep; 2021 Apr; 11(1):9117. PubMed ID: 33907289 [TBL] [Abstract][Full Text] [Related]
11. Polyglutamine length-dependent interaction of Hsp40 and Hsp70 family chaperones with truncated N-terminal huntingtin: their role in suppression of aggregation and cellular toxicity. Jana NR; Tanaka M; Wang Gh; Nukina N Hum Mol Genet; 2000 Aug; 9(13):2009-18. PubMed ID: 10942430 [TBL] [Abstract][Full Text] [Related]
12. Heat shock promotes inclusion body formation of mutant huntingtin (mHtt) and alleviates mHtt-induced transcription factor dysfunction. Chen JY; Parekh M; Seliman H; Bakshinskaya D; Dai W; Kwan K; Chen KY; Liu AYC J Biol Chem; 2018 Oct; 293(40):15581-15593. PubMed ID: 30143534 [TBL] [Abstract][Full Text] [Related]
13. Stress response mechanisms in protein misfolding diseases: Profiling a cellular model of Huntington's disease. Almeida LM; Oliveira Â; Oliveira JMA; Pinho BR Arch Biochem Biophys; 2023 Sep; 745():109711. PubMed ID: 37541563 [TBL] [Abstract][Full Text] [Related]
14. Huntingtin interacting protein HYPK is a negative regulator of heat shock response and is downregulated in models of Huntington's Disease. Das S; Bhattacharyya NP Exp Cell Res; 2016 May; 343(2):107-117. PubMed ID: 27017930 [TBL] [Abstract][Full Text] [Related]
15. Allosteric activation of Hsp70 reduces mutant huntingtin levels, the clustering of N-terminal fragments, and their nuclear accumulation. Pinho BR; Almeida LM; Duchen MR; Oliveira JMA Life Sci; 2021 Nov; 285():120009. PubMed ID: 34600937 [TBL] [Abstract][Full Text] [Related]
16. Downregulation of glial genes involved in synaptic function mitigates Huntington's disease pathogenesis. Onur TS; Laitman A; Zhao H; Keyho R; Kim H; Wang J; Mair M; Wang H; Li L; Perez A; de Haro M; Wan YW; Allen G; Lu B; Al-Ramahi I; Liu Z; Botas J Elife; 2021 Apr; 10():. PubMed ID: 33871358 [TBL] [Abstract][Full Text] [Related]
17. Abnormal degradation of the neuronal stress-protective transcription factor HSF1 in Huntington's disease. Gomez-Pastor R; Burchfiel ET; Neef DW; Jaeger AM; Cabiscol E; McKinstry SU; Doss A; Aballay A; Lo DC; Akimov SS; Ross CA; Eroglu C; Thiele DJ Nat Commun; 2017 Feb; 8():14405. PubMed ID: 28194040 [TBL] [Abstract][Full Text] [Related]
18. The induction levels of heat shock protein 70 differentiate the vulnerabilities to mutant huntingtin among neuronal subtypes. Tagawa K; Marubuchi S; Qi ML; Enokido Y; Tamura T; Inagaki R; Murata M; Kanazawa I; Wanker EE; Okazawa H J Neurosci; 2007 Jan; 27(4):868-80. PubMed ID: 17251428 [TBL] [Abstract][Full Text] [Related]
19. Luteolin as potential treatment for Huntington's disease: Insights from a transgenic mouse model. Mohammed A; Ramadan A; Elnour AA; Saeed AAAM; Al Mazrouei N; Alsulami FT; Alqarni YS; Menon V; Amoodi AA; Abdalla SF CNS Neurosci Ther; 2024 Sep; 30(9):e70025. PubMed ID: 39228080 [TBL] [Abstract][Full Text] [Related]
20. Geldanamycin activates a heat shock response and inhibits huntingtin aggregation in a cell culture model of Huntington's disease. Sittler A; Lurz R; Lueder G; Priller J; Lehrach H; Hayer-Hartl MK; Hartl FU; Wanker EE Hum Mol Genet; 2001 Jun; 10(12):1307-15. PubMed ID: 11406612 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]